Latest Intervacc News & Updates

See the latest news and media coverage for Intervacc. We track all announcements, press releases, and industry mentions in real time, all in one place.

Intervacc

Swedish animal health vaccine developer

intervacc.se

Headquarters: Stockholm, Sweden
Company type: Public company
Number of employees: 20–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Intervacc

In short: Intervacc reported strategic progress for Strangvac, including a US expansion and a 12-month immunity application to the EMA.

Company announcements

July 30 Intervacc

Intervacc applies for 12 months immunity for Strangvac

The application is a type II variation to the EMA, supported by data showing protective antibody levels persist for 12 months.

July 29 Intervacc

Intervacc exports Strangvac to New Zealand after special import approval

The approval follows a request from NZEHA after a strangles outbreak. Initial delivery of 1,200 doses. Intervacc intends to apply for formal approval.

May 22 Intervacc

Intervacc has evaluated American strep bacteria strain ahead of clinical studies

The evaluation shows that the strain is identical to the European strain, enabling cost savings and time efficiencies ahead of US launch of Strangvac.

May 13 Intervacc

Intervacc publishes interim report for the first quarter of 2026

Net sales decreased and operating profit deteriorated.

Media coverage

August 28 FinanzNachrichten.de

Current recommendations for the INTERVACC stock

Buy INTERVACC stock now? Analyses and price targets: Advertising notice: The approval of the base prospectus by the BaFin is not to be understood as its endorsement of the offered securities. We...

August 20 ZoneBourse

Intervacc AB (publ) publishes its results for the second quarter and the first half-year ended 30 June 2026

Intervacc AB has published its financial results for the second quarter and the first half-year ended 30 June 2026. For the second quarter, the...

August 5 Finanzen.net

Initial estimates: Intervacc Registered announces quarterly results for the most recent quarter

Intervacc Registered is expected to invite to the regular financial conference on 20.08.2026 and will publish the figures for the most recent quarter, which ended on 30.06.2026. The forecast of...

July 29 FinanzNachrichten.de

Intervacc AB: Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac

Intervacc AB (publ) today announces that it has submitted a Type II variation application to the European Medicines Agency (EMA) for Strangvac, the company's innovative...

Never miss news about Intervacc

Track Intervacc and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Intervacc competitors & trending companies

Browse news for competitors to Intervacc and other trending companies.